Next generation single dose vaccine adjuvants


College of Veterinary Medicine, The Ohio State University, Ohio, US

I.P. Brief: 

We offer an adjuvant strategy for existing or new vaccine formulations to elicit protective immunity from a single dose. In addition to adult applications, we have shown efficacy in neonates with/without maternal antibodies. Our adjuvant combination is proven in an animal model predictive for human infectious diseases.


vaccine adjuvant, human infectious disease, veterinary medicine

Primary Industry: 

Medical, Pharmaceuticals, Personal Care

Full IP Descriptions available on-site.